blaIMP-27 on transferable plasmids in Proteus mirabilis and Providencia rettgeri

R. F. Potter, M. A. Wallace, Allison Rebecca McMullen, J. Prusa, C. L. Stallings, C. A.D. Burnham, G. Dantas

Research output: Contribution to journalArticle

Abstract

Objectives: A carbapenem-resistant Providencia rettgeri (PR1) isolate was recovered from a wound infection in Missouri, USA. This isolate possessed an EDTA-inhibitable carbapenemase that was unidentified using the Xpert CARBA-R assay. Our objective was to elucidate the molecular determinant of carbapenem resistance in this isolate. We then sought to test the transmissibility of blaIMP-27 loci in clinical P. rettgeri and Proteus mirabilis isolates. Methods: In October 2016 the novel ambler Class B carbapenemase blaIMP-27, was reported in two different Proteus mirabilis (PM185 and PM187) isolates. Broth mating assays for transfer of carbapenemase activity were performed for the three clinical isolates with recipient sodium azide-resistant Escherichia coli J53. Antibiotic susceptibility testing and phenotypic carbapenemase activity testing were performed on the clinical isolates, J53 and transconjugants using the Kirby–Bauer disc diffusion method according to CLSI guidelines. Plasmid DNA from PM187, PR1 and their transconjugants were used as input for Nextera Illumina sequencing libraries and sequenced on a NEXTSEQ platform. Results: PR1 was resistant to both imipenem and meropenem. PM187 and PR1 could transfer resistance to E. coli through plasmid conjugation (pPM187 and pPR1). pPM187 had a virB/virD4 type IV secretion system whereas pPR1 had a traB/traD type IV secretion system. Conclusion: Two of three blaIMP-27-bearing clinical isolates tested could conjugate resistance into E. coli. The resulting transconjugants became positive for phenotypic carbapenemase production but did not pass clinical resistance breakpoints. blaIMP-27 can be transmitted on different plasmid replicon types that rely on distinct classes of type IV secretion system for horizontal transfer.

Original languageEnglish (US)
Pages (from-to)1019.e5-1019.e8
JournalClinical Microbiology and Infection
Volume24
Issue number9
DOIs
StatePublished - Sep 1 2018

Fingerprint

Providencia
Proteus mirabilis
Plasmids
Carbapenems
meropenem
Escherichia coli
Sodium Azide
Replicon
Imipenem
Wound Infection
Edetic Acid
carbapenemase
Guidelines
Anti-Bacterial Agents
DNA
Type IV Secretion Systems

Keywords

  • Carbapenem resistance
  • Horizontal gene transfer
  • Proteus mirabilis
  • Providencia rettgeri
  • bla

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Potter, R. F., Wallace, M. A., McMullen, A. R., Prusa, J., Stallings, C. L., Burnham, C. A. D., & Dantas, G. (2018). blaIMP-27 on transferable plasmids in Proteus mirabilis and Providencia rettgeri. Clinical Microbiology and Infection, 24(9), 1019.e5-1019.e8. https://doi.org/10.1016/j.cmi.2018.02.018

blaIMP-27 on transferable plasmids in Proteus mirabilis and Providencia rettgeri. / Potter, R. F.; Wallace, M. A.; McMullen, Allison Rebecca; Prusa, J.; Stallings, C. L.; Burnham, C. A.D.; Dantas, G.

In: Clinical Microbiology and Infection, Vol. 24, No. 9, 01.09.2018, p. 1019.e5-1019.e8.

Research output: Contribution to journalArticle

Potter, RF, Wallace, MA, McMullen, AR, Prusa, J, Stallings, CL, Burnham, CAD & Dantas, G 2018, 'blaIMP-27 on transferable plasmids in Proteus mirabilis and Providencia rettgeri', Clinical Microbiology and Infection, vol. 24, no. 9, pp. 1019.e5-1019.e8. https://doi.org/10.1016/j.cmi.2018.02.018
Potter, R. F. ; Wallace, M. A. ; McMullen, Allison Rebecca ; Prusa, J. ; Stallings, C. L. ; Burnham, C. A.D. ; Dantas, G. / blaIMP-27 on transferable plasmids in Proteus mirabilis and Providencia rettgeri. In: Clinical Microbiology and Infection. 2018 ; Vol. 24, No. 9. pp. 1019.e5-1019.e8.
@article{acd001b7e6e347aaa1b7f7d50eb74354,
title = "blaIMP-27 on transferable plasmids in Proteus mirabilis and Providencia rettgeri",
abstract = "Objectives: A carbapenem-resistant Providencia rettgeri (PR1) isolate was recovered from a wound infection in Missouri, USA. This isolate possessed an EDTA-inhibitable carbapenemase that was unidentified using the Xpert CARBA-R assay. Our objective was to elucidate the molecular determinant of carbapenem resistance in this isolate. We then sought to test the transmissibility of blaIMP-27 loci in clinical P. rettgeri and Proteus mirabilis isolates. Methods: In October 2016 the novel ambler Class B carbapenemase blaIMP-27, was reported in two different Proteus mirabilis (PM185 and PM187) isolates. Broth mating assays for transfer of carbapenemase activity were performed for the three clinical isolates with recipient sodium azide-resistant Escherichia coli J53. Antibiotic susceptibility testing and phenotypic carbapenemase activity testing were performed on the clinical isolates, J53 and transconjugants using the Kirby–Bauer disc diffusion method according to CLSI guidelines. Plasmid DNA from PM187, PR1 and their transconjugants were used as input for Nextera Illumina sequencing libraries and sequenced on a NEXTSEQ platform. Results: PR1 was resistant to both imipenem and meropenem. PM187 and PR1 could transfer resistance to E. coli through plasmid conjugation (pPM187 and pPR1). pPM187 had a virB/virD4 type IV secretion system whereas pPR1 had a traB/traD type IV secretion system. Conclusion: Two of three blaIMP-27-bearing clinical isolates tested could conjugate resistance into E. coli. The resulting transconjugants became positive for phenotypic carbapenemase production but did not pass clinical resistance breakpoints. blaIMP-27 can be transmitted on different plasmid replicon types that rely on distinct classes of type IV secretion system for horizontal transfer.",
keywords = "Carbapenem resistance, Horizontal gene transfer, Proteus mirabilis, Providencia rettgeri, bla",
author = "Potter, {R. F.} and Wallace, {M. A.} and McMullen, {Allison Rebecca} and J. Prusa and Stallings, {C. L.} and Burnham, {C. A.D.} and G. Dantas",
year = "2018",
month = "9",
day = "1",
doi = "10.1016/j.cmi.2018.02.018",
language = "English (US)",
volume = "24",
pages = "1019.e5--1019.e8",
journal = "Clinical Microbiology and Infection",
issn = "1198-743X",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - blaIMP-27 on transferable plasmids in Proteus mirabilis and Providencia rettgeri

AU - Potter, R. F.

AU - Wallace, M. A.

AU - McMullen, Allison Rebecca

AU - Prusa, J.

AU - Stallings, C. L.

AU - Burnham, C. A.D.

AU - Dantas, G.

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Objectives: A carbapenem-resistant Providencia rettgeri (PR1) isolate was recovered from a wound infection in Missouri, USA. This isolate possessed an EDTA-inhibitable carbapenemase that was unidentified using the Xpert CARBA-R assay. Our objective was to elucidate the molecular determinant of carbapenem resistance in this isolate. We then sought to test the transmissibility of blaIMP-27 loci in clinical P. rettgeri and Proteus mirabilis isolates. Methods: In October 2016 the novel ambler Class B carbapenemase blaIMP-27, was reported in two different Proteus mirabilis (PM185 and PM187) isolates. Broth mating assays for transfer of carbapenemase activity were performed for the three clinical isolates with recipient sodium azide-resistant Escherichia coli J53. Antibiotic susceptibility testing and phenotypic carbapenemase activity testing were performed on the clinical isolates, J53 and transconjugants using the Kirby–Bauer disc diffusion method according to CLSI guidelines. Plasmid DNA from PM187, PR1 and their transconjugants were used as input for Nextera Illumina sequencing libraries and sequenced on a NEXTSEQ platform. Results: PR1 was resistant to both imipenem and meropenem. PM187 and PR1 could transfer resistance to E. coli through plasmid conjugation (pPM187 and pPR1). pPM187 had a virB/virD4 type IV secretion system whereas pPR1 had a traB/traD type IV secretion system. Conclusion: Two of three blaIMP-27-bearing clinical isolates tested could conjugate resistance into E. coli. The resulting transconjugants became positive for phenotypic carbapenemase production but did not pass clinical resistance breakpoints. blaIMP-27 can be transmitted on different plasmid replicon types that rely on distinct classes of type IV secretion system for horizontal transfer.

AB - Objectives: A carbapenem-resistant Providencia rettgeri (PR1) isolate was recovered from a wound infection in Missouri, USA. This isolate possessed an EDTA-inhibitable carbapenemase that was unidentified using the Xpert CARBA-R assay. Our objective was to elucidate the molecular determinant of carbapenem resistance in this isolate. We then sought to test the transmissibility of blaIMP-27 loci in clinical P. rettgeri and Proteus mirabilis isolates. Methods: In October 2016 the novel ambler Class B carbapenemase blaIMP-27, was reported in two different Proteus mirabilis (PM185 and PM187) isolates. Broth mating assays for transfer of carbapenemase activity were performed for the three clinical isolates with recipient sodium azide-resistant Escherichia coli J53. Antibiotic susceptibility testing and phenotypic carbapenemase activity testing were performed on the clinical isolates, J53 and transconjugants using the Kirby–Bauer disc diffusion method according to CLSI guidelines. Plasmid DNA from PM187, PR1 and their transconjugants were used as input for Nextera Illumina sequencing libraries and sequenced on a NEXTSEQ platform. Results: PR1 was resistant to both imipenem and meropenem. PM187 and PR1 could transfer resistance to E. coli through plasmid conjugation (pPM187 and pPR1). pPM187 had a virB/virD4 type IV secretion system whereas pPR1 had a traB/traD type IV secretion system. Conclusion: Two of three blaIMP-27-bearing clinical isolates tested could conjugate resistance into E. coli. The resulting transconjugants became positive for phenotypic carbapenemase production but did not pass clinical resistance breakpoints. blaIMP-27 can be transmitted on different plasmid replicon types that rely on distinct classes of type IV secretion system for horizontal transfer.

KW - Carbapenem resistance

KW - Horizontal gene transfer

KW - Proteus mirabilis

KW - Providencia rettgeri

KW - bla

UR - http://www.scopus.com/inward/record.url?scp=85044259926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044259926&partnerID=8YFLogxK

U2 - 10.1016/j.cmi.2018.02.018

DO - 10.1016/j.cmi.2018.02.018

M3 - Article

VL - 24

SP - 1019.e5-1019.e8

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - 9

ER -